BioCentury | Apr 7, 2008
Finance

IPO queue

...$1B TBD TBD Mkt Novagali (Euronext Paris) 7/19/07 TBD TBD TBD TBD Ph III compl ULive...
BioCentury | Jan 14, 2008
Finance

IPO queue

...TBD Ph III compl MonoSol Rx 5/14/07 4M $68M $16-$18 15M In the clinic (F) ULive...
BioCentury | Oct 1, 2007
Finance

IPO queue

...$75M $14-$16 16.4M Mkt MonoSol Rx 5/14/07 4M $68M $16-$18 15M In the clin (D) ULive...
BioCentury | Jul 2, 2007
Finance

IPO queue

...III 1Q08 MonoSol Rx 5/14/07 TBD Up to $86.3M TBD TBD In the clin (C) Ulive...
BioCentury | May 21, 2007
Finance

Ebb & Flow

...MonoSol develops dissolving thin film pharmaceuticals. Trading on tech In the U.K., technology commercialization company ULive...
...the University of Liverpool. ULive establishes joint ventures and spinout companies, and arranges out-licensing deals. ULive...
...IPO that raised £9 million ($16.5 million). W.H. Ireland is advisor and broker for the ULive...
BioCentury | May 15, 2007
Financial News

ULive proposes IPO

...Ireland is advisor and broker for the offering, which is expected to close in June. ULive...
...by establishing JVs and spinout companies, as well as by arranging out-licensing deals. In return, ULive...
Items per page:
1 - 6 of 6
BioCentury | Apr 7, 2008
Finance

IPO queue

...$1B TBD TBD Mkt Novagali (Euronext Paris) 7/19/07 TBD TBD TBD TBD Ph III compl ULive...
BioCentury | Jan 14, 2008
Finance

IPO queue

...TBD Ph III compl MonoSol Rx 5/14/07 4M $68M $16-$18 15M In the clinic (F) ULive...
BioCentury | Oct 1, 2007
Finance

IPO queue

...$75M $14-$16 16.4M Mkt MonoSol Rx 5/14/07 4M $68M $16-$18 15M In the clin (D) ULive...
BioCentury | Jul 2, 2007
Finance

IPO queue

...III 1Q08 MonoSol Rx 5/14/07 TBD Up to $86.3M TBD TBD In the clin (C) Ulive...
BioCentury | May 21, 2007
Finance

Ebb & Flow

...MonoSol develops dissolving thin film pharmaceuticals. Trading on tech In the U.K., technology commercialization company ULive...
...the University of Liverpool. ULive establishes joint ventures and spinout companies, and arranges out-licensing deals. ULive...
...IPO that raised £9 million ($16.5 million). W.H. Ireland is advisor and broker for the ULive...
BioCentury | May 15, 2007
Financial News

ULive proposes IPO

...Ireland is advisor and broker for the offering, which is expected to close in June. ULive...
...by establishing JVs and spinout companies, as well as by arranging out-licensing deals. In return, ULive...
Items per page:
1 - 6 of 6